NYSEAMERICAN:NSPR - InspireMD Stock Price, Forecast & News

InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."

InspireMD shares reverse split on the morning of Monday, April 1st 2019. The 1-50 reverse split was announced on Tuesday, March 26th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 29th 2019. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 2 shares after the split.

InspireMD Inc (NYSEAMERICAN:NSPR) issued its quarterly earnings results on Tuesday, November, 12th. The medical equipment provider reported ($1.26) earnings per share for the quarter, topping analysts' consensus estimates of ($1.35) by $0.09. The medical equipment provider had revenue of $0.94 million for the quarter, compared to the consensus estimate of $1.40 million. View InspireMD's Earnings History.

InspireMD is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for InspireMD.

InspireMD issued an update on its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1-1.025 million, compared to the consensus revenue estimate of $1.6 million.

1 analysts have issued 1-year price targets for InspireMD's shares. Their forecasts range from $5.00 to $5.00. On average, they expect InspireMD's share price to reach $5.00 in the next twelve months. This suggests a possible upside of 254.6% from the stock's current price. View Analyst Price Targets for InspireMD.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for InspireMD.

Headlines about NSPR stock have been trending somewhat positive this week, according to InfoTrie. The research group rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. InspireMD earned a news impact score of 2.0 on InfoTrie's scale. They also gave news coverage about the medical equipment provider a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an effect on the stock's share price in the immediate future. View News Stories for InspireMD.

InspireMD saw a decrease in short interest in January. As of January 15th, there was short interest totalling 105,400 shares, a decrease of 9.4% from the December 31st total of 116,300 shares. Based on an average daily volume of 259,000 shares, the days-to-cover ratio is currently 0.4 days. Approximately 8.6% of the company's stock are sold short. View InspireMD's Current Options Chain.

Some companies that are related to InspireMD include LiDCO Group (LID), Deltex Medical Group (DEMG), Zecotek Photonics (ZMS), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS).

Based on aggregate information from My MarketBeat watchlists, some companies that other InspireMD investors own include Palatin Technologies (PTN), TransEnterix (TRXC), Catalyst Pharmaceuticals (CPRX), NovaBay Pharmaceuticals (NBY), Inovio Pharmaceuticals (INO), Novavax (NVAX), Nokia Oyj (NOK), AVEO Pharmaceuticals (AVEO), Curis (CRIS) and Rexahn Pharmaceuticals (REXN).

InspireMD's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Wedbush Securities Inc. (1.67%). Company insiders that own InspireMD stock include Paul Stuka and Thomas J Kester. View Institutional Ownership Trends for InspireMD.

NSPR stock was purchased by a variety of institutional investors in the last quarter, including Wedbush Securities Inc.. View Insider Buying and Selling for InspireMD.

Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NSPR stock can currently be purchased for approximately $1.41.

InspireMD has a market capitalization of $5.12 million. InspireMD employs 43 workers across the globe.View Additional Information About InspireMD.

The official website for InspireMD is http://www.inspiremd.com/.

InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553.